Dr. Hönle AG provided earnings guidance for the financial year 2021/2022. The Management Board expects revenues of between EUR 130 million and EUR 140 million and an operating result (EBIT) of between EUR 14 million and EUR 17 million in financial year 2021/2022.
Market Closed -
Other stock markets
|
After market 12:59:26 pm | |||
19.4 EUR | -2.27% | 19.42 | +0.13% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.86% | 130M | |
+15.99% | 86.04B | |
+19.64% | 36.93B | |
+25.58% | 34.44B | |
+8.61% | 27.97B | |
+5.75% | 27.27B | |
+7.52% | 27.11B | |
+21.55% | 26.56B | |
+20.00% | 25.25B | |
+21.57% | 18.53B |
- Stock Market
- Equities
- HNL Stock
- News Dr. Hönle AG
- Dr. Hönle AG Provides Earnings Guidance for the Financial Year 2021/2022